CD30 - Overview: CD30 Immunostain, Technical Component Only

Identification of CD30 expression in a variety of neoplasms

CA25 - Overview: Cancer Antigen 125 (CA 125), Serum

Evaluating individuals' response to ovarian cancer therapy Predicting recurrent ovarian cancer This test is not useful for cancer detection screening in the normal population.

CARTA - Overview: Carbamazepine, Total, Serum

Monitoring therapy Determining compliance Assessing toxicity

COUO - Overview: Cobalt Occupational Exposure, Random, Urine

Screening for occupational exposure to cobalt

CARU - Overview: Cyclic Adenosine Monophosphate (cAMP), Urinary Excretion, Serum and Urine

Differential diagnosis of hypercalcemia As an adjunct to serum parathyroid hormone measurements, especially in the diagnosis of parathyroid hormone resistance states, such as pseudohypoparathyroidism

CARNP - Overview: Carbapenemase Detection-Carba NP Test, Varies

Confirming carbapenemase production from pure isolates of Enterobacterales or Pseudomonas aeruginosa

FVAG - Overview: Fungal Culture, Vaginal

Monitoring therapy for vulvovaginitis Managing chronic recurring disease Determining the etiology of infectious vaginitis when other tests have been uninformative

FDERM - Overview: Fungal Culture, Dermal

Recovery and identification of dermatophyte fungi from hair, skin, and nail infected specimens

GLYCS - Overview: Glycine Receptor Alpha1 IgG, Cell Binding Assay, Serum

Evaluating patients with suspected autoimmune stiff-person spectrum disorders (stiff-person syndrome, stiff-limb, stiff trunk or progressive encephalomyelitis with rigidity and myoclonus [PERM]) using serum specimens

THEVI - Overview: Hemoglobinopathy Interpretation

Interpretation of results for the evaluation of thalassemias and hemoglobinopathies Evaluation of microcytosis Extensive and economical diagnosis and classification of hemoglobinopathies or thalassemia including complex...

GBM - Overview: Glomerular Basement Membrane Antibodies, IgG, Serum

Evaluating patients with clinical features of anti-glomerular basement disease, including rapidly progressive glomerulonephritis or pulmonary hemorrhage

GGT - Overview: Gamma-Glutamyltransferase (GGT), Serum

Diagnosing and monitoring hepatobiliary disease, it is currently the most sensitive enzymatic indicator of liver disease Ascertaining whether observed elevations of alkaline phosphatase are due to skeletal disease (normal...

PBUOE - Overview: Lead Occupational Exposure, Random, Urine

Detecting clinically significant lead exposure due to occupational exposure This test is not a substitute for blood lead screening.

HALO - Overview: Haloperidol, Serum

Optimizing haloperidol dosage Monitoring patient compliance Assessing toxicity

HAD - Overview: Huntington Disease, Molecular Analysis, Varies

Molecular confirmation of clinically suspected cases of Huntington disease (HD) Presymptomatic testing for individuals with a family history of HD and a documented expansion in the HTT gene

KRASW - Overview: KRAS Somatic Mutation Analysis, Peritoneal Fluid

Staging of the pancreatic ductal adenocarcinoma(1)

MMAU - Overview: Methylmalonic Acid, Quantitative, Urine

Evaluating children with signs and symptoms of methylmalonic acidemia using urine specimens Evaluating individuals with signs and symptoms associated with a variety of causes of vitamin B12 (cobalamin) deficiency

MMAP - Overview: Methylmalonic Acid, Quantitative, Plasma

Evaluating children with signs and symptoms of methylmalonic acidemia using plasma specimens Evaluating individuals with signs and symptoms associated with a variety of causes of vitamin B12 (cobalamin) deficiency

K11CS - Overview: Kelch-Like Protein 11 Antibody, Cell Binding Assay, Serum

Evaluating patients with paraneoplastic or autoimmune encephalitis (brainstem encephalitis or limbic encephalitis or cerebellar ataxia) using serum specimens

KKBRP - Overview: Kingella kingae, Molecular Detection, PCR, Blood

Aiding in the diagnosis of Kingella kingae infection using whole blood specimens

K11CC - Overview: Kelch-Like Protein 11 Antibody, Cell Binding Assay, Spinal Fluid

Evaluating patients with paraneoplastic or autoimmune encephalitis (brainstem encephalitis or limbic encephalitis or cerebellar ataxia) using spinal fluid specimens

LPSBF - Overview: Lipase, Body Fluid

Determining whether pancreatic inflammation or pancreatic fistula may be contributing to a pathological accumulation of fluid

PBCU - Overview: Lead/Creatinine Ratio, Urine

Detecting clinically significant lead exposure using random urine specimens This test is not a substitute for blood lead screening.

HAEV0 - Overview: Hemolytic Anemia Summary Interpretation

Incorporating and summarizing subsequent results into an overall interpretation for the HAEV1 / Hemolytic Anemia Evaluation, Blood

IMIPR - Overview: Imipramine and Desipramine, Serum

Monitoring imipramine and desipramine concentrations during therapy Evaluating potential imipramine and desipramine toxicity May aid in evaluating patient compliance

IDH2 - Overview: IHD2, R172K Mutation, Immunostain, Technical Component Only

Identification of IDH2 R172K mutant protein in angioimmunoblastic T-cell lymphoma or acute myeloid leukemia

LAMO - Overview: Lamotrigine, Serum

Monitoring serum concentration of lamotrigine Assessing compliance Adjusting lamotrigine dose in patients receiving other anticonvulsant drugs that interact pharmacokinetically with lamotrigine

GATOL - Overview: Galactitol, Quantitative, Urine

Monitoring effectiveness of treatment in patients with galactosemia Establishing a baseline level prior to initiating treatment for galactosemia

FENTU - Overview: Fentanyl with Metabolite Confirmation, Random, Urine

Detection and confirmation of illicit drug use involving fentanyl

CLFIB - Overview: Fibrinogen, Clauss, Plasma

Detecting increased or decreased fibrinogen (factor 1) concentration of acquired or congenital origin Monitoring severity and treatment of disseminated intravascular coagulation and fibrinolysis

LGBWB - Overview: Globotriaosylsphingosine, Blood

Screening of patients with Fabry disease when a serum specimen is not available This test should not be used for newborn screening followup.

GLYCC - Overview: Glycine Receptor Alpha1 IgG, Cell Binding Assay, Spinal Fluid

Evaluating patients with suspected autoimmune stiff-person spectrum disorders (stiff-person syndrome, stiff-limb, stiff trunk, or progressive encephalomyelitis with rigidity and myoclonus [PERM]) using spinal fluids specimens

GLUCG - Overview: Glucagon Immunostain, Technical Component Only

Aiding in the study of islet-cell tumors and some endocrine tumors of the gastrointestinal tract

MYGLU - Overview: Myoglobin, Random, Urine

Confirming the presence of a myopathy

MMAS - Overview: Methylmalonic Acid, Quantitative, Serum

Evaluating children with signs and symptoms of methylmalonic acidemia using serum specimens Evaluating individuals with signs and symptoms associated with a variety of causes of vitamin B12 (cobalamin) deficiency

NIUC - Overview: Nickel/Creatinine Ratio, Random, Urine

Measurement of nickel concentration for biomonitoring nickel exposure

MOLPS - Overview: Molybdenum, Serum

Monitoring of parenteral nutrition Monitoring metallic prosthetic implant wear As an indicator of molybdenum cofactor deficiency

MA2EC - Overview: Ma2 Antibody, ELISA, Spinal Fluid

Evaluating patients with suspected paraneoplastic encephalitides using spinal fluid specimens

MA2ES - Overview: Ma2 Antibody by ELISA, Serum

Evaluating patients with suspected paraneoplastic encephalitides using serum specimens

HPP - Overview: Pancreatic Polypeptide, Plasma

Detecting pancreatic endocrine tumors Assessing vagal nerve function after meal or sham feeding

B6PA - Overview: Pyridoxic Acid, Plasma

Determining the concentration of pyridoxic acid in the assessment of vitamin B6 status

OPATM - Overview: Opiate Confirmation, Meconium

Detecting maternal prenatal opiate/opioid use up to 5 months before birth

CSPCF - Overview: Plasma Cell Proliferative Disorder, Pre-Analysis Cell Sorting, Bone Marrow

Aiding in the diagnosis of new cases of multiple myeloma or other plasma cell proliferative disorders Sorting plasma cells for fluorescence in situ hybridization analysis

PEC - Overview: Pecan-Food, IgE, Serum

Establishing a diagnosis of an allergy to pecan-food Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or anaphylactic episode -To confirm sensitization...

288PD - Overview: Programmed Death-Ligand 1 (PD-L1) (28-8), Semi-Quantitative Immunohistochemistry, Manual

Identification of neoplasms expressing programmed cell death 1-ligand 1(clone 28-8)

PCPMC - Overview: Phencyclidine (PCP) Confirmation, Meconium

Detection of in utero to phencyclidine (PCP) exposure up to 5 months before birth

SULFU - Overview: Sulfate, 24 Hour, Urine

Assessing the nutrition intake of animal protein The calculation of urinary supersaturation of various crystals or stones

ROTA - Overview: Rotavirus Antigen, Feces

Investigation of patients with diarrhea, particularly infants, the elderly, and immunocompromised patients Investigation of nosocomial diarrhea

C5B9 - Overview: SC5b-9 Level Terminal Complement Complex, Plasma

Detecting increased complement activation

TB2LN - Overview: Susceptibility, Mycobacterium tuberculosis Complex, Second Line, Varies

Determination of Mycobacterium tuberculosis complex minimal inhibitory concentrations to second-line antimicrobial agents